Stevens-Johnson Syndrome: Causes, Symptoms and USMLE Review
Stevens-Johnson syndrome (SJS) is a rare but serious disorder involving the skin and mucous membranes. It is most commonly associated with a medication exposure and can progress rapidly, making early recognition important. For medical students and USMLE candidates, recognizing the characteristic clinical presentation and common triggers is an important part of exam preparation.
What Is Stevens-Johnson Syndrome?
Stevens-Johnson syndrome is a severe mucocutaneous reaction characterized by epidermal injury and detachment. It typically begins with nonspecific symptoms such as fever, fatigue, or malaise before painful skin lesions and mucosal involvement develop.
SJS is considered part of a spectrum of severe cutaneous adverse reactions that includes toxic epidermal necrolysis (TEN). The extent of epidermal detachment is one of the factors used to distinguish the two conditions.
Common Causes and Triggers
Medications are among the most important triggers of SJS. Drugs that have been associated with the condition include:
- Sulfonamide antibiotics
- Certain anticonvulsants
- Allopurinol
- Some nonsteroidal anti-inflammatory drugs
- Certain antibiotics
Infections can also be associated with SJS, although medication-related cases are particularly important when reviewing potential causes in clinical questions.
A patient’s recent medication history is therefore an important part of evaluating suspected SJS.
Signs and Symptoms
SJS often starts with a prodromal illness followed by painful skin and mucosal lesions.
Common features can include:
- Fever
- Malaise
- Skin pain
- Targetoid or atypical target lesions
- Blistering
- Epidermal detachment
- Oral involvement
- Ocular involvement
- Genital or other mucosal involvement
Mucosal involvement is an important clinical clue. Patients may develop painful erosions affecting the mouth, eyes, or genital region.
Unlike many uncomplicated drug rashes, SJS can involve significant epidermal injury and systemic complications.
Stevens-Johnson Syndrome vs Toxic Epidermal Necrolysis
SJS and toxic epidermal necrolysis represent different degrees of the same severe mucocutaneous disease spectrum.
The distinction is primarily based on the percentage of body surface area affected by epidermal detachment:
- SJS: less than 10% body surface area
- SJS/TEN overlap: approximately 10–30%
- TEN: more than 30%
These figures are useful for examination purposes, but clinical assessment should consider the complete presentation rather than relying on one measurement alone.
Diagnosis
Diagnosis is primarily clinical, supported by the patient’s history and physical examination. Recent medication exposure, the timing of symptoms, skin findings, mucosal involvement, and extent of epidermal detachment are important considerations.
A skin biopsy may be performed when the diagnosis needs confirmation or when other conditions need to be excluded.
Management
Suspected SJS is a medical emergency. The suspected causative medication should be identified and discontinued promptly under appropriate medical supervision.
Management may involve:
- Immediate withdrawal of the suspected offending medication
- Supportive fluid and electrolyte management
- Wound and skin care
- Pain management
- Nutritional support
- Monitoring for infection and organ complications
- Ophthalmologic assessment when the eyes are involved
- Appropriate specialist and critical-care involvement when required
Patients with extensive disease may require management in a specialized burn unit or intensive-care setting.
Treatment decisions should be guided by current clinical protocols and specialist recommendations because the severity and complications can vary considerably between patients.
Important USMLE Points
When reviewing SJS for an examination, several clues are particularly important:
- Recent medication exposure can provide an important diagnostic clue.
- Fever followed by painful skin lesions should raise concern for a severe cutaneous reaction.
- Mucosal involvement is a key feature.
- Epidermal detachment distinguishes SJS/TEN from many less severe drug eruptions.
- SJS involves less than 10% body surface area, while TEN involves more than 30%.
- Stopping the suspected causative medication is a critical early management step.
- Supportive care is an important component of treatment.
Why SJS Can Be Confused with Other Conditions
Several conditions can produce rashes, blisters, or mucosal lesions. Depending on the presentation, the differential diagnosis can include erythema multiforme, autoimmune blistering disorders, staphylococcal scalded skin syndrome, and other severe drug reactions.
For exam questions, the combination of a recent medication exposure, systemic symptoms, painful skin lesions, mucosal involvement, and epidermal detachment can help distinguish SJS/TEN from other diagnoses.
Final Takeaway
Stevens-Johnson syndrome is an important medical and USMLE topic because it combines pharmacology, dermatology, immunology, and emergency management. Recognizing the relationship between medication exposure, mucosal involvement, painful skin lesions, and epidermal detachment can help students identify the condition in clinical questions.
Because SJS can become life-threatening, real-world diagnosis and treatment should always be based on current clinical guidance and professional medical assessment.
Continue the Discussion
Have questions about Stevens-Johnson syndrome, medication-related skin reactions, or how SJS and TEN are tested in USMLE-style questions?
Join the ValueMD forum discussion to ask questions and discuss the topic with other medical students and healthcare professionals.
Visit the new ValueMD forum discussion
Disclaimer: This resource is intended for medical education and general informational purposes. It is not a substitute for professional medical advice, diagnosis, or treatment. Clinical decisions should be based on current medical guidelines and the advice of qualified healthcare professionals.